Abstract:Background: Studies have shown inconsistent associations between serum uric acid (SUA) levels and mortality in peritoneal dialysis (PD) patients. We conducted this meta-analysis to determine whether SUA levels were associated with cardiovascular or all-cause mortality in PD patients. Methods: PubMed, Embase, Web of Science, the Cochrane Library, CNKI, VIP, Wanfang Database, and trial registry databases were systematically searched up to April 11, 2021. Cohort studies of SUA levels and cardiovascular or all-cause mortality in PD patients were obtained. Random effect models were used to calculate the pooled adjusted hazard ratio ( HR ) and corresponding 95% confidence interval ( CI ). Sensitivity analyses were conducted to assess the robustness of the pooled results. Subgroup analyses and meta-regression analyses were performed to explore the sources of heterogeneity. Funnel plots, Begg's tests, and Egger's tests were conducted to evaluate potential publication bias. The GRADE approach was used to rate the certainty of evidence. This study was registered with PROSPERO, CRD42021268739. Results: Seven studies covering 18,113 PD patients were included. Compared with the middle SUA levels, high SUA levels increased the risk of all-cause mortality ( HR = 1.74, 95% CI : 1.26–2.40, I 2 = 34.8%, τ 2 = 0.03), low SUA levels were not statistically significant with the risk of all-cause or cardiovascular mortality ( HR = 1.04, 95% CI : 0.84–1.29, I 2 = 43.8%, τ 2 = 0.03; HR = 0.89, 95% CI : 0.65–1.23, I 2 = 36.3%, τ 2 = 0.04; respectively). Compared with the low SUA levels, high SUA levels were not statistically associated with an increased risk of all-cause or cardiovascular mortality ( HR = 1.19, 95% CI : 0.59–2.40, I 2 = 88.2%, τ 2 = 0.44; HR = 1.22, 95% CI : 0.39–3.85, I 2 = 89.3%, τ 2 = 0.92; respectively). Conclusion: Compared with middle SUA levels, high SUA levels are associated with an increased risk of all-cause mortality in PD patients. SUA levels may not be associated with cardiovascular mortality. More high-level studies, especially randomized controlled trials, are needed to determine the association between SUA levels and cardiovascular or all-cause mortality in PD patients. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021268739 , identifier: CRD42021268739.

The Significance of Follow-Up Serum Uric Acid Levels in Predicting All-Cause Mortality and Cardiovascular Mortality in Peritoneal Dialysis Patients.

Effects of Serum Uric Acid Level on All?cause Death and Cardiovascular Death in Patients of Maintaining Peritoneal Dialysis

The Associations of Uric Acid, Cardiovascular and All-Cause Mortality in Peritoneal Dialysis Patients.

Relationship between serum uric acid, all-cause mortality and cardiovascular mortality in peritoneal dialysis patients: systematic review and meta-analysis of cohort studies

High serum uric acid level is a mortality risk factor in peritoneal dialysis patients: a retrospective cohort study

Serum Uric Acid and Cardiovascular or All-Cause Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis

The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study

Serum Uric Acid and Risk of Incident Chronic Kidney Disease: a National Cohort Study and Updated Meta-Analysis.

The Association between Baseline Serum Lipids and Mortality in Peritoneal Dialysis Patients

An Inverse Relationship between Hyperuricemia and Mortality in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

The association between the serum uric acid to creatinine ratio and all-cause mortality in elderly hemodialysis patients

Serum Uric Acid and Mortality Risk Among Hemodialysis Patients

The Associations of Blood Pressure Parameters with All-Cause and Cardiovascular Mortality in Peritoneal Dialysis Patients: a Cohort Study in China.

High Alkaline Phosphatase and Low Intact Parathyroid Hormone Associate with Worse Clinical Outcome in Peritoneal Dialysis Patients

Distinct Prognostic Role of Serum Uric Acid Levels for Predicting All-Cause Mortality among Chinese Adults Aged 45~75 Years with and Without Diabetes

Associations Between Home Blood Pressure and Mortality in Peritoneal Dialysis

P1493CORRELATION BETWEEN END-DIALYSIS OVER-WEIGHT IN INITIAL STAGE OF HEMODIALYSIS AND PROGNOSIS IN INCIDENT HEMODIALYSIS PATIENTS

Impact of Initial Dialysis Modality on the Survival of Patients with ESRD in Eastern China: a Propensity-Matched Study.

Associations of Mean Arterial Pressure Levels with Mortality in Patients with Peritoneal Dialysis

Serum uric acid levels and health outcomes in CKD: a prospective cohort study

Soluble urokinase plasminogen activator receptor is associated with cardiovascular calcification in peritoneal dialysis patients